Cargando…

The added value of ordinal analysis in clinical trials: an example in traumatic brain injury

INTRODUCTION: In clinical trials, ordinal outcome measures are often dichotomized into two categories. In traumatic brain injury (TBI) the 5-point Glasgow outcome scale (GOS) is collapsed into unfavourable versus favourable outcome. Simulation studies have shown that exploiting the ordinal nature of...

Descripción completa

Detalles Bibliográficos
Autores principales: Roozenbeek, Bob, Lingsma, Hester F, Perel, Pablo, Edwards, Phil, Roberts, Ian, Murray, Gordon D, Maas, Andrew IR, Steyerberg, Ewout W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218993/
https://www.ncbi.nlm.nih.gov/pubmed/21586148
http://dx.doi.org/10.1186/cc10240
_version_ 1782216774294437888
author Roozenbeek, Bob
Lingsma, Hester F
Perel, Pablo
Edwards, Phil
Roberts, Ian
Murray, Gordon D
Maas, Andrew IR
Steyerberg, Ewout W
author_facet Roozenbeek, Bob
Lingsma, Hester F
Perel, Pablo
Edwards, Phil
Roberts, Ian
Murray, Gordon D
Maas, Andrew IR
Steyerberg, Ewout W
author_sort Roozenbeek, Bob
collection PubMed
description INTRODUCTION: In clinical trials, ordinal outcome measures are often dichotomized into two categories. In traumatic brain injury (TBI) the 5-point Glasgow outcome scale (GOS) is collapsed into unfavourable versus favourable outcome. Simulation studies have shown that exploiting the ordinal nature of the GOS increases chances of detecting treatment effects. The objective of this study is to quantify the benefits of ordinal analysis in the real-life situation of a large TBI trial. METHODS: We used data from the CRASH trial that investigated the efficacy of corticosteroids in TBI patients (n = 9,554). We applied two techniques for ordinal analysis: proportional odds analysis and the sliding dichotomy approach, where the GOS is dichotomized at different cut-offs according to baseline prognostic risk. These approaches were compared to dichotomous analysis. The information density in each analysis was indicated by a Wald statistic. All analyses were adjusted for baseline characteristics. RESULTS: Dichotomous analysis of the six-month GOS showed a non-significant treatment effect (OR = 1.09, 95% CI 0.98 to 1.21, P = 0.096). Ordinal analysis with proportional odds regression or sliding dichotomy showed highly statistically significant treatment effects (OR 1.15, 95% CI 1.06 to 1.25, P = 0.0007 and 1.19, 95% CI 1.08 to 1.30, P = 0.0002), with 2.05-fold and 2.56-fold higher information density compared to the dichotomous approach respectively. CONCLUSIONS: Analysis of the CRASH trial data confirmed that ordinal analysis of outcome substantially increases statistical power. We expect these results to hold for other fields of critical care medicine that use ordinal outcome measures and recommend that future trials adopt ordinal analyses. This will permit detection of smaller treatment effects.
format Online
Article
Text
id pubmed-3218993
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32189932011-11-17 The added value of ordinal analysis in clinical trials: an example in traumatic brain injury Roozenbeek, Bob Lingsma, Hester F Perel, Pablo Edwards, Phil Roberts, Ian Murray, Gordon D Maas, Andrew IR Steyerberg, Ewout W Crit Care Research INTRODUCTION: In clinical trials, ordinal outcome measures are often dichotomized into two categories. In traumatic brain injury (TBI) the 5-point Glasgow outcome scale (GOS) is collapsed into unfavourable versus favourable outcome. Simulation studies have shown that exploiting the ordinal nature of the GOS increases chances of detecting treatment effects. The objective of this study is to quantify the benefits of ordinal analysis in the real-life situation of a large TBI trial. METHODS: We used data from the CRASH trial that investigated the efficacy of corticosteroids in TBI patients (n = 9,554). We applied two techniques for ordinal analysis: proportional odds analysis and the sliding dichotomy approach, where the GOS is dichotomized at different cut-offs according to baseline prognostic risk. These approaches were compared to dichotomous analysis. The information density in each analysis was indicated by a Wald statistic. All analyses were adjusted for baseline characteristics. RESULTS: Dichotomous analysis of the six-month GOS showed a non-significant treatment effect (OR = 1.09, 95% CI 0.98 to 1.21, P = 0.096). Ordinal analysis with proportional odds regression or sliding dichotomy showed highly statistically significant treatment effects (OR 1.15, 95% CI 1.06 to 1.25, P = 0.0007 and 1.19, 95% CI 1.08 to 1.30, P = 0.0002), with 2.05-fold and 2.56-fold higher information density compared to the dichotomous approach respectively. CONCLUSIONS: Analysis of the CRASH trial data confirmed that ordinal analysis of outcome substantially increases statistical power. We expect these results to hold for other fields of critical care medicine that use ordinal outcome measures and recommend that future trials adopt ordinal analyses. This will permit detection of smaller treatment effects. BioMed Central 2011 2011-05-17 /pmc/articles/PMC3218993/ /pubmed/21586148 http://dx.doi.org/10.1186/cc10240 Text en Copyright ©2011 Roozenbeek et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Roozenbeek, Bob
Lingsma, Hester F
Perel, Pablo
Edwards, Phil
Roberts, Ian
Murray, Gordon D
Maas, Andrew IR
Steyerberg, Ewout W
The added value of ordinal analysis in clinical trials: an example in traumatic brain injury
title The added value of ordinal analysis in clinical trials: an example in traumatic brain injury
title_full The added value of ordinal analysis in clinical trials: an example in traumatic brain injury
title_fullStr The added value of ordinal analysis in clinical trials: an example in traumatic brain injury
title_full_unstemmed The added value of ordinal analysis in clinical trials: an example in traumatic brain injury
title_short The added value of ordinal analysis in clinical trials: an example in traumatic brain injury
title_sort added value of ordinal analysis in clinical trials: an example in traumatic brain injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218993/
https://www.ncbi.nlm.nih.gov/pubmed/21586148
http://dx.doi.org/10.1186/cc10240
work_keys_str_mv AT roozenbeekbob theaddedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT lingsmahesterf theaddedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT perelpablo theaddedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT edwardsphil theaddedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT robertsian theaddedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT murraygordond theaddedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT maasandrewir theaddedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT steyerbergewoutw theaddedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT roozenbeekbob addedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT lingsmahesterf addedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT perelpablo addedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT edwardsphil addedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT robertsian addedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT murraygordond addedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT maasandrewir addedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury
AT steyerbergewoutw addedvalueofordinalanalysisinclinicaltrialsanexampleintraumaticbraininjury